Cost-effectiveness analysis of the tislelizumab versus docetaxel for advanced or metastatic non-small-cell lung cancer in China
Article in Frontiers in Public Health (July 2024)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Article in Frontiers in Public Health (July 2024)
Article in Frontiers in Pharmacology (June 2024)
Preprint in Research Square (March 2024)